Fuji Pharma Co., Ltd. (FUP.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 08:10AM CEST
| Previous close | 9.05 |
| Open | 9.40 |
| Bid | 9.20 x 70000 |
| Ask | 9.75 x 70000 |
| Day's range | 9.40 - 9.40 |
| 52-week range | 6.65 - 12.60 |
| Volume | |
| Avg. volume | 12 |
| Market cap | 230.589M |
| Beta (5Y monthly) | 0.38 |
| PE ratio (TTM) | 7.52 |
| EPS (TTM) | 1.25 |
| Earnings date | 06 Aug 2024 - 13 Aug 2024 |
| Forward dividend & yield | 0.28 (3.09%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
Business WireVistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen’s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan
SOUTH SAN FRANCISCO, Calif. & TOKYO, September 05, 2023--Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system (CNS) disorders, and Fuji Pharma Co., Ltd. ("Fuji") (TSE: 4554), a pharmaceutical company specializing in development, manufacture and marketing in the fields of women’s healthcare and acute medical care, today announced they have entered into a tim
© 2024 Yahoo. All rights reserved.